Bystolic and Rhinitis - a phase IV clinical study of FDA data

Summary:

Rhinitis is reported as a side effect among people who take Bystolic (nebivolol hydrochloride), especially for people who are female, 60+ old, also take Vitamin D3, and have Cystinuria.

The phase IV clinical study analyzes which people have Rhinitis when taking Bystolic. It is created by eHealthMe based on reports of 18,660 people who have side effects when taking Bystolic from the FDA, and is updated regularly.

What is Bystolic?

Bystolic has active ingredients of nebivolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 20,662 Bystolic users. Check the latest studies of Bystolic.

What is Rhinitis?

Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose) is found to be associated with 977 drugs and 968 conditions by eHealthMe. Check the latest studies of Rhinitis.

On Aug, 06, 2026

18,660 people reported to have side effects when taking Bystolic.
Among them, 12 people (0.06%) have Rhinitis.

Among these 12 people:

What is the gender of people who have Rhinitis when taking Bystolic? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Rhinitis when taking Bystolic? *

What are other drugs people take besides Bystolic? *

Vitamin D3: 4 people, 33.33%
Zetia: 3 people, 25.00%
Lipitor: 2 people, 16.67%
Thiola Ec: 2 people, 16.67%
Potassium Citrate: 2 people, 16.67%
Fluticasone Propionate: 2 people, 16.67%
Folic Acid: 2 people, 16.67%
Dexilant: 2 people, 16.67%
Singulair: 2 people, 16.67%
Valtrex: 2 people, 16.67%

What are other side effects people have besides Rhinitis? *

Sinusitis (inflammation of sinus): 3 people, 25.00%
Headache (pain in head): 3 people, 25.00%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 3 people, 25.00%
Otitis (ear infection): 2 people, 16.67%
Pulmonary Congestion (congestion in the lungs): 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Rashes (redness): 2 people, 16.67%
Eye Infection: 2 people, 16.67%
Joint Pain: 2 people, 16.67%
Nosebleed (bleeding from nose): 2 people, 16.67%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 2 people, 16.67%
Cystinuria (formation of cystine stones in the kidneys, ureter, and bladder): 2 people, 16.67%
Primary Immunodeficiency Syndrome: 1 person, 8.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Drowsiness: 1 person, 8.33%
Diarrhea: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Bystolic and have Rhinitis?

- Check whether Rhinitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bystolic:

Bystolic (20,662 reports)

Rhinitis treatments and more:

Rhinitis (15,448 reports)

Browse all side effects of Bystolic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rhinitis:

Rhinitis (977 drugs)

Browse all the conditions that are associated with Rhinitis:

Rhinitis (968 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nebivolol hydrochloride (the active ingredients of Bystolic) and Bystolic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.